DNAJC5 and malaria: The characterisation of novel malaria vaccine-induced immune responses to the NANP region of CSP similar to that of the licensed vaccine (RTS,S/AS01) can be carried out through measurements of antibody peak concentrations and the kinetics of waning responses via assays such as ELISA.